Novartis Investigative Site

Culiacan, State of Mexico 80020

0 studies enrolling now · 5 studies all time

What they study most

Ankylosing Spondylitis, Autoimmunity, Inflammation, Multiple Sclerosis, Non-radiographic Spondyloarthritis, Spondylitis, Ankylosing

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients — Completed